[Control mechanism of cognitive function by t-type membrane potential-dependent calcium channel].
Shigeki
S
Moriguchi
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology*; D000818:Animals; D020747:Calcium Channels, T-Type / Q000502:physiology*; D006801:Humans; D007189:Indans / Q000494:pharmacology / Q000627:therapeutic use; D018697:Nootropic Agents / Q000494:pharmacology / Q000627:therapeutic use; D013141:Spiro Compounds / Q000494:pharmacology / Q000627:therapeutic use
D020747:Calcium Channels, T-Type; D007189:Indans; D018697:Nootropic Agents; D013141:Spiro Compounds; C511224:spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one